focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksABC.L Share News (ABC)

  • There is currently no data for ABC

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

BROKER RATINGS SUMMARY: HSBC Raises Berkeley And McCarthy & Stone

Mon, 09th Sep 2019 09:29

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning:

----------

FTSE 100

----------

HSBC RAISES BERKELEY GROUP TO 'BUY' ('HOLD') - PRICE TARGET 4540 (4130) PENCE

----------

UBS RAISES BERKELEY GROUP PRICE TARGET TO 4800 (4700) PENCE - 'BUY'

----------

HSBC CUTS TAYLOR WIMPEY PRICE TARGET TO 210 (230) PENCE - 'BUY'

----------

HSBC CUTS PERSIMMON PRICE TARGET TO 2750 (2960) PENCE - 'BUY'

----------

HSBC CUTS BARRATT DEVELOPMENTS PRICE TARGET TO 750 (770) PENCE - 'BUY'

----------

GOLDMAN SACHS CUTS ST JAMES'S PLACE PRICE TARGET TO 980 (1030) PENCE - 'NEUTRAL'

----------

GOLDMAN CUTS LEGAL & GENERAL PRICE TARGET TO 245 (260) PENCE - 'NEUTRAL'

----------

DEUTSCHE BANK RAISES ASTRAZENECA PRICE TARGET TO 7800 (7600) PENCE - 'BUY'

----------

BERENBERG CUTS CENTRICA PRICE TARGET TO 80 (140) PENCE - 'HOLD'

----------

BERENBERG RAISES LONDON STOCK EXCHANGE PRICE TARGET TO 8115 (6340) PENCE - 'BUY'

----------

FTSE 250

----------

BERENBERG CUTS ENTERTAINMENT ONE TO 'HOLD' ('BUY') - TARGET 572 (475) PENCE

----------

UBS CUTS ASHMORE GROUP PRICE TARGET TO 480 (505) PENCE - 'NEUTRAL'

----------

DAVY CUTS WIZZ AIR TO 'NEUTRAL' ('OUTPERFORM')

----------

RBC CUTS DUNELM GROUP PRICE TARGET TO 850 (900) PENCE - 'UNDERPERFORM'

----------

BARCLAYS CUTS ASHMORE GROUP PRICE TARGET TO 520 (540) PENCE - 'EQUAL WEIGHT'

----------

BARCLAYS RAISES ULTRA ELECTRONICS TO 'EQUAL WEIGHT' ('UNDERWEIGHT') - TARGET 2000 (1120) PENCE

----------

HSBC CUTS REDROW PRICE TARGET TO 770 (790) PENCE - 'BUY'

----------

HSBC CUTS BOVIS HOMES PRICE TARGET TO 1300 (1350) PENCE - 'BUY'

----------

HSBC CUTS ASTON MARTIN LAGONDA PRICE TARGET TO 533 (1032) PENCE - 'HOLD'

----------

HSBC RAISES MCCARTHY & STONE TO 'BUY' ('HOLD') - TARGET 160 (150) PENCE

----------

HSBC RAISES CREST NICHOLSON PRICE TARGET TO 540 (510) PENCE - 'BUY'

----------

HSBC RAISES BELLWAY PRICE TARGET TO 4290 (4250) PENCE - 'BUY'

----------

MORGAN STANLEY RAISES MITCHELLS & BUTLERS TO 'OVERWEIGHT' ('EQUAL-WEIGHT')

----------

JEFFERIES RAISES PLAYTECH PRICE TARGET TO 620 (570) PENCE - 'BUY'

----------

JEFFERIES RAISES INTERMEDIATE CAPITAL PRICE TARGET TO 1600 (1570) PENCE - 'BUY'

----------

OTHER MAIN MARKET AND AIM

----------

RBC INITIATES SPIRE HEALTHCARE WITH 'OUTPERFORM' - TARGET 149 PENCE

----------

RBC CUTS ABCAM PRICE TARGET TO 1300 (1410) PENCE - 'SECTOR PERFORM'

----------

More News
25 Jul 2016 15:15

Abcam describes 'another successful year' ahead of results

(ShareCast News) - Life science research tools supplier Abcam posted a trading update for the year to 30 June on Monday, ahead of the publication of its financial results, due 12 September. The AIM-traded firm described "another successful year" and claimed to have achieved above market revenue grow

Read more
20 Jun 2016 15:35

Abcam announces Wood as new finance chief

(ShareCast News) - Life science research tools firm Abcam announced on Monday the appointment of Gavin Wood as its chief financial officer. The AIM-traded firm said Wood, who is the former executive vice president and CFO of Affymetrix, is to join the company on 18 July and succeed Jeff Iliffe after

Read more
20 Jun 2016 06:40

Abcam Appoints Gavin Wood As New Chief Financial Officer

Read more
5 Apr 2016 08:32

BROKER RATINGS SUMMARY: Liberum Upgrades Babcock To Hold From Sell

Read more
14 Mar 2016 09:33

BROKER RATINGS SUMMARY: HSBC And Merrill Lynch Downgrade Admiral

Read more
10 Mar 2016 16:13

Dividends Calendar - Week Ahead

Read more
7 Mar 2016 14:30

Abcam shares sink on news of lower earnings

(ShareCast News) - Abcam tried to paint its interim results as strong on Monday, with the biotechnology company making increased investment for the future, though the market did not agree in afternoon trading. The AIM-traded firm saw revenue rise 17.2% on a constant currency basis and 18% on a repor

Read more
7 Mar 2016 07:51

Abcam Confident In Meeting Full-Year Targets As COO To Retire

Read more
29 Feb 2016 16:08

Earnings, Trading Statements Calendar - Week Ahead

Read more
26 Jan 2016 09:43

BROKER RATINGS SUMMARY: UBS Upgrades RBS To Buy From Neutral

Read more
25 Jan 2016 10:36

Avacta Poaches Abcam's Cotrel For Chief Commercial Officer Role

Read more
25 Jan 2016 07:56

Abcam Expects Revenue Growth Of 17% For First Half

Read more
5 Jan 2016 09:43

BROKER RATINGS SUMMARY: S&P CapIQ Cuts Next To Buy From Strong Buy

Read more
27 Nov 2015 15:44

Dividends Calendar - Week Ahead

Read more
11 Nov 2015 16:40

DIRECTOR DEALINGS: Abcam CEO Buys GBP19,343 Of Stock After AxioMx Deal

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.